PL442642A1 - Method of producing a nutraceutical with immunomodulating and immunostimulating properties for the immune system and the nutraceutical produced using this method - Google Patents
Method of producing a nutraceutical with immunomodulating and immunostimulating properties for the immune system and the nutraceutical produced using this methodInfo
- Publication number
- PL442642A1 PL442642A1 PL442642A PL44264222A PL442642A1 PL 442642 A1 PL442642 A1 PL 442642A1 PL 442642 A PL442642 A PL 442642A PL 44264222 A PL44264222 A PL 44264222A PL 442642 A1 PL442642 A1 PL 442642A1
- Authority
- PL
- Poland
- Prior art keywords
- sup
- raw material
- cfu
- nutraceutical
- total number
- Prior art date
Links
- 239000002417 nutraceutical Substances 0.000 title abstract 3
- 235000021436 nutraceutical agent Nutrition 0.000 title abstract 3
- 230000002519 immonomodulatory effect Effects 0.000 title abstract 2
- 210000000987 immune system Anatomy 0.000 title abstract 2
- 230000003308 immunostimulating effect Effects 0.000 title abstract 2
- 239000002994 raw material Substances 0.000 abstract 9
- 241000894006 Bacteria Species 0.000 abstract 4
- 241000193755 Bacillus cereus Species 0.000 abstract 2
- 241000588724 Escherichia coli Species 0.000 abstract 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 abstract 2
- 238000001035 drying Methods 0.000 abstract 2
- 230000002906 microbiologic effect Effects 0.000 abstract 2
- 239000002245 particle Substances 0.000 abstract 2
- 239000000843 powder Substances 0.000 abstract 2
- 241001061264 Astragalus Species 0.000 abstract 1
- 229920000858 Cyclodextrin Polymers 0.000 abstract 1
- 240000004534 Scutellaria baicalensis Species 0.000 abstract 1
- 235000017089 Scutellaria baicalensis Nutrition 0.000 abstract 1
- 235000006533 astragalus Nutrition 0.000 abstract 1
- 238000004108 freeze drying Methods 0.000 abstract 1
- 239000007903 gelatin capsule Substances 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 abstract 1
- 238000000859 sublimation Methods 0.000 abstract 1
- 230000008022 sublimation Effects 0.000 abstract 1
- 210000004233 talus Anatomy 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/539—Scutellaria (skullcap)
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Botany (AREA)
- Mycology (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medical Informatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Neurosurgery (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
Abstract
Przedmiotem zgłoszenia jest sposób wytwarzania nutraceutyku o właściwościach immunomodulujących i immunostymulujących układ odpornościowy charakteryzujący się tym, że do mieszalnika wprowadza się cyklodekstrynę o wilgotności nie wyższej niż 9 – 11%, następnie dodaje się do niej kolejno susz z traganka błoniastego, otrzymanego na drodze suszenia konwekcyjnego bądź sublimacyjnego, o zawartość suchej masy surowca 85 - 90% i wysokiej czystości mikrobiologicznej tj. ogólna liczba bakterii mezofilnych < 10<sup>2</sup> jtk/gram surowca ogólna liczba bakterii psychrofilnych < 10<sup>2</sup> jtk/g surowca, liczba pleśni i drożdży < 10<sup>2</sup> jtk/g; Bacillus cereus — nieobecne w 1 g surowca, E.coli nieobecne w 1 g surowca, w postaci proszku rozdrobnionego do cząstek nie mniejszych niż 0,5 mm i nie większych niż 0,7 mm, i miesza się z prędkością 100 obr./min, po czym dodaje się susz z tarczycy bajkalskiej otrzymany na drodze suszenia konwekcyjnego lub sublimacyjnego (o zawartości suchej masy w przedziale od 85 do 90% i wysokiej czystości mikrobiologicznej tj. ogólna liczba bakterii mezofilnych < 10<sup>2</sup> jtk/gram surowca ogólna liczba bakterii psychrofilnych < 10<sup>2</sup> jtk/g surowca, liczba pleśni i drożdży < 10<sup>2</sup> jtk/g; Bacillus cereus - nieobecne w 1 g surowca, E. coli nieobecne w 1 g surowca), w postaci proszku o wielkości cząstek nie mniejszych niż 0,7 mm i nie większych niż 0,8 mm, całość miesza się, do uzyskania jednolitej mieszaniny, a następnie gotowy produkt konfekcjonuje się do żelatynowych kapsułek twardych po nie więcej niż 320 mg, co odpowiada jednej porcji produktu.The subject of the application is a method for producing a nutraceutical with immunomodulating and immunostimulating properties of the immune system, characterized by the fact that cyclodextrin with a humidity of not more than 9 - 11% is introduced into the mixer, then dried astragalus, obtained by convection drying or drying, is successively added to it. sublimation, with a raw material dry matter content of 85 - 90% and high microbiological purity, i.e. total number of mesophilic bacteria < 10<sup>2</sup> cfu/gram of raw material, total number of psychrophilic bacteria < 10<sup>2</sup> cfu /g of raw material, number of molds and yeasts < 10<sup>2</sup> cfu/g; Bacillus cereus - absent in 1 g of raw material, E. coli absent in 1 g of raw material, in the form of powder crushed to particles not smaller than 0.5 mm and not larger than 0.7 mm, and mixed at a speed of 100 rpm , then the dried Baikal skullcap obtained by convection or freeze drying is added (with dry matter content ranging from 85 to 90% and high microbiological purity, i.e. total number of mesophilic bacteria < 10<sup>2</sup> cfu/ gram of raw material, total number of psychrophilic bacteria < 10<sup>2</sup> cfu/g of raw material, number of molds and yeasts < 10<sup>2</sup> cfu/g; Bacillus cereus - absent in 1 g of raw material, E. coli absent in 1 g of raw material), in the form of a powder with a particle size not smaller than 0.7 mm and not larger than 0.8 mm, all mixed until a uniform mixture is obtained, and then the finished product is packaged into hard gelatin capsules after no more than 320 mg, which corresponds to one serving of the product.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PL442642A PL442642A1 (en) | 2022-10-26 | 2022-10-26 | Method of producing a nutraceutical with immunomodulating and immunostimulating properties for the immune system and the nutraceutical produced using this method |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PL442642A PL442642A1 (en) | 2022-10-26 | 2022-10-26 | Method of producing a nutraceutical with immunomodulating and immunostimulating properties for the immune system and the nutraceutical produced using this method |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL442642A1 true PL442642A1 (en) | 2024-04-29 |
Family
ID=90885639
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL442642A PL442642A1 (en) | 2022-10-26 | 2022-10-26 | Method of producing a nutraceutical with immunomodulating and immunostimulating properties for the immune system and the nutraceutical produced using this method |
Country Status (1)
| Country | Link |
|---|---|
| PL (1) | PL442642A1 (en) |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103054947A (en) * | 2013-01-18 | 2013-04-24 | 广西壮族自治区海洋研究所 | Pharmaceutical composition for preventing and treating trachinotus ovatus scabies disease |
| CN103142842A (en) * | 2013-04-07 | 2013-06-12 | 龚定军 | Traditional Chinese medicine for treating diabetes mellitus |
| PL236876B1 (en) * | 2016-06-15 | 2021-02-22 | Witpol Spolka Z Ograniczona Odpowiedzialnoscia | Antioxidant mixture |
-
2022
- 2022-10-26 PL PL442642A patent/PL442642A1/en unknown
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103054947A (en) * | 2013-01-18 | 2013-04-24 | 广西壮族自治区海洋研究所 | Pharmaceutical composition for preventing and treating trachinotus ovatus scabies disease |
| CN103142842A (en) * | 2013-04-07 | 2013-06-12 | 龚定军 | Traditional Chinese medicine for treating diabetes mellitus |
| PL236876B1 (en) * | 2016-06-15 | 2021-02-22 | Witpol Spolka Z Ograniczona Odpowiedzialnoscia | Antioxidant mixture |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Sharifi et al. | Use of whey protein isolate and gum Arabic for the co-encapsulation of probiotic Lactobacillus plantarum and phytosterols by complex coacervation: Enhanced viability of probiotic in Iranian white cheese | |
| EP2730646B2 (en) | Drying lactic acid bacteria and new compositions | |
| Fritzen-Freire et al. | Microencapsulation of bifidobacteria by spray drying in the presence of prebiotics | |
| EP2318511B1 (en) | Bacterial composition | |
| CN108523137A (en) | A kind of preparation method of the probiotic granulate of acid and bile salt tolerance | |
| BRPI0711839A2 (en) | probiotic microorganism compositions, granules containing them, preparation process and uses thereof | |
| CA2660767A1 (en) | Probiotic microorganisms for the reduction of manure odor | |
| TWI542284B (en) | Granule containing livestock's blood and sheel as additives for fish feed or formula feed and manufacturing method of it | |
| Sogut et al. | Whey protein isolate-and carrageenan-based edible films as carriers of different probiotic bacteria | |
| CN107875136A (en) | A kind of Amoxicillin pharmaceutical preparation and preparation method thereof | |
| Tan et al. | In situ alginate crosslinking during spray-drying of lactobacilli probiotics promotes gastrointestinal-targeted delivery | |
| UA81225C2 (en) | Solid composition containing bacillus-type non-pathogenic bacterial spores | |
| Sansone et al. | Particle technology applied to a lactose/NaCMC blend: Production and characterization of a novel and stable spray-dried ingredient | |
| PL442642A1 (en) | Method of producing a nutraceutical with immunomodulating and immunostimulating properties for the immune system and the nutraceutical produced using this method | |
| KR20190104395A (en) | Dried microorganisms with excipients | |
| AU2013276851B2 (en) | Method for the production of a porous powder product containing a probiotic or other microorganisms | |
| CN107307429B (en) | Film coating premix of probiotic preparation and preparation method and application thereof | |
| AU2018244082A1 (en) | Process for the preparation of powdered probiotic formulations for monograstic animals. | |
| Rodríguez Arreola et al. | In vivo assessment and characterization of lactic acid bacteria with probiotic profile isolated from human milk powder | |
| JP6467475B2 (en) | Method for producing lactic acid bacteria-containing chocolate with a long distribution period | |
| WO2023094652A1 (en) | Compositions for increased stability of bacteria | |
| WO2023094653A1 (en) | Fat and wax microencapsulated ambient stable bacteria and probiotics | |
| Rojas-Espina et al. | Optimizing the viability of microencapsulated Lactiplantibacillus plantarum using response surface methodology for dietary probiotic delivery | |
| JP2022111196A (en) | Composition, production method, and usage | |
| RU2132196C1 (en) | Method of eubiotic biosporin preparing |